An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.
about
Anergic B Cells: Precarious On-Call Warriors at the Nexus of Autoimmunity and False-Flagged PathogensMaturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic AntibodyProgress in HIV-1 vaccine development.Humanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.Polyreactivity and autoreactivity among HIV-1 antibodies.High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination.DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titersEliminating antibody polyreactivity through addition of N-linked glycosylation.Differences in HIV type 1 neutralization breadth in 2 geographically distinct cohorts in Africa.HIV-Infected Spleens Present Altered Follicular Helper T Cell (Tfh) Subsets and Skewed B Cell Maturation.A systematic review of syphilis serological treatment outcomes in HIV-infected and HIV-uninfected persons: rethinking the significance of serological non-responsiveness and the serofast state after therapy.Can immunological principles and cross-disciplinary science illuminate the path to vaccines for HIV and other global health challenges?HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions.Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.Aviremia 10 Years Postdiscontinuation of Antiretroviral Therapy Initiated During Primary Human Immunodeficiency Virus-1 Infection and Association With Gag-Specific T-Cell ResponsesBroadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathyEnvelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virusThe role of Fc receptors in HIV prevention and therapy.Functional Versatility of AGY Serine Codons in Immunoglobulin Variable Region Genes.Enhanced antibody responses to an HIV-1 membrane-proximal external region antigen in mice reconstituted with cultured lymphocytes.The potential role of retroviruses in autoimmunity.Breaching peripheral tolerance promotes the production of HIV-1-neutralizing antibodies.Pathological Role of Anti-CD4 Antibodies in HIV-Infected Immunologic Nonresponders Receiving Virus-Suppressive Antiretroviral Therapy.HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies.Kaleidoscope of autoimmune diseases in HIV infection.Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development.Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.Will studies in individuals with systemic lupus erythematosus be the key to future HIV vaccine design?Immunological tolerance as a barrier to protective HIV humoral immunity.Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies.What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination? Breaking through Immunity's Glass Ceiling.Nonorgan-specific autoantibodies in HIV-infected patients in the HAART era.The quest for an antibody-based HIV vaccine.B-Cell-Activating Factor and the B-Cell Compartment in HIV/SIV Infection.Cross-reactivity of HIV vaccine responses and the microbiome.Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding site.Advances in HIV-1 Vaccine Development.Altered Ratio of T Follicular Helper Cells to T Follicular Regulatory Cells Correlates with Autoreactive Antibody Response in Simian Immunodeficiency Virus-Infected Rhesus Macaques.Distinct systemic microbiome and microbial translocation are associated with plasma level of anti-CD4 autoantibody in HIV infection
P2860
Q26774672-70B8D50C-8426-4DCF-A7F5-239B30C2B794Q27644415-BC55C913-CCA8-439D-80EE-68E9860D5530Q27693849-AE11AAE9-422D-466F-8060-68ECA71356EAQ30234773-87885C80-2CE6-4F5A-8C01-16A481CA3741Q34114798-73CCA6E2-10DC-448B-B428-6F42CE3661E5Q34992787-A252FD14-C1CD-445F-B62D-075C023E7B44Q35624357-27A5FA5F-285D-40A8-9341-FB2A6E530C24Q35640984-07EDCAAC-9023-4136-AEE7-1560D0479A2CQ35684786-8A4A9CDB-43C7-40DA-9397-EE4B30715E3BQ35715634-D6512BAF-9565-4C8C-A299-6684A4CFC32DQ35821193-33C46D3C-90D9-4B04-A562-8C76F27C00B2Q35825170-4B674E54-6D89-4A18-90CE-3EFF36CD6C2CQ35923859-E3395531-954E-40C9-95B2-2A38CF8579B8Q36249933-C806D502-D3CA-441C-87EE-6B86320656CDQ36290038-1D070F42-A399-48EB-8C65-908733669D01Q36319368-19E45FCD-33CD-47D0-8298-40B1041B7DBBQ36764988-19C592A8-21F2-44F8-B3B6-C753F486E8FEQ37072545-5C97095C-C935-4E1C-9140-7DE374AAEFDBQ37113972-1B9DE459-2725-42AB-8168-4133C7CD68C4Q37427477-BE204EA0-5034-4B48-874B-4A67FF791009Q37730206-21D2D0EA-D225-4BE7-949E-668FEC6D3401Q38673415-AB6122C2-0A74-4AD3-ABD5-0EB74B3C9B2EQ38683449-20EA10FA-11DE-467B-992B-AD98A21F5F36Q38789184-1682EE49-C2AC-4BC0-B264-8F0169E00988Q38897259-067A71BE-C1DA-49AD-91A8-22B88FEC7D52Q38932786-695196E8-2493-42FE-960D-0D56036F0009Q39108751-1AD0C40F-ED4C-42D3-8D32-97BAF7B446FDQ39108760-83B9B95F-2075-4074-83A5-E2E44CA9174DQ39160496-45D5B6EF-3EC4-4973-95DB-686E3DAAB0CEQ39447992-55EED432-6F89-4F7D-B87E-FE4CA1ECDDFCQ40103798-FD6B63FC-0536-46AA-AFFC-8B9B9C785151Q40166335-BD33732C-318A-4059-8756-AC9C087B04F1Q40303001-FD9D4B8D-347A-420A-A824-91013EE2415CQ40354016-B8202D61-B67F-41A5-9C75-24891EE324F7Q47169594-676CF7A0-C204-44EC-9344-44DFF90F29BCQ47611203-6403FD30-39BC-4352-B697-26FC25660AFFQ50420466-87722067-B4F9-4AD2-8A5C-4EB90B104426Q52609661-EAF469B9-D5F5-4400-80B7-A3F338D571A0Q55405842-EB535C00-DA03-4507-8FA2-0802B4034CF3Q58701275-FC434C82-524D-483E-AB13-75B588478FF7
P2860
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.
@en
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.
@nl
type
label
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.
@en
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.
@nl
prefLabel
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.
@en
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.
@nl
P2093
P2860
P50
P356
P1476
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.
@en
P2093
Abby J Cooper
Daniel M Kozink
Florence Perrin
Georgia D Tomaras
Guang Yang
Hua-Xin Liao
Joshua Eudailey
Kevin Wiehe
Krisha McKee
P2860
P304
P356
10.1172/JCI73441
P407
P577
2014-03-10T00:00:00Z